Anticonvulsant drugs fail to modulate chemotherapy-induced cytotoxicity and growth inhibition of human malignant glioma cells

Journal of Neuro-Oncology

Volumn 37, Issue 3, 1998, Pages 191-198

  Ständer, Marko ^a   Dichgans, Johannes ^a   Weller, Michael ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Carbamazepine; Chemotherapy; Epilepsy; Malignant glioma; Phenytoin; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL;

ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; CARBAMAZEPINE; CELL DIVISION; CELL SURVIVAL; GLIOMA; HUMANS; OSMOLAR CONCENTRATION; PHENYTOIN; TUMOR CELLS, CULTURED; VALPROIC ACID;

EID: 0031929305     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005870122744     Document Type: Article

References (25)

1. Moots PL, Maciunas RJ, Eisert D R, Parker R A, Laporte K, Abou-Khalil B: The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52: 717-724, 1995
2. Glantz J, Cole BF, Friedberg MH, Lethi E, Choy H, Furie K, Akerley W, Wahlberg L, Lekos A, Louis S: A randomized, blinded, placebocontrolled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 46: 985-991, 1996
3. Kornblith PL, Callahan LV, Caswell PA : Growth-inhibitory effects of diphenylhydantoin on human brain tumor cells in culture. Neurosurgery 2: 122-127, 1978
4. Regan CM, German AMC, Larsson OM, Maguire C, Martin ML, Schousboe A, Williams DC: In vitro screening for anticonvulsant-induced teratogenesis in neural primary cultures and cell lines. Int J Dev Neurosci 8: 143-150, 1990
5. Martin ML, Regan CM: The anticonvulsant valproate teratogen restricts the glial cell cycle at a defined point in the mid-G1 phase. Brain Res 554: 223-228, 1991
6. Kornblith PL, Hartnett LC, Anderson LP, Quindlen EA, Smith BH: Growth-inhibitory effects of diphenylhydantoin on murine astrocytomas. Neurosurgery 5: 259-263, 1979
7. Gao XM, Margolis RL, Leeds P, Hough C, Post RM, Chuang DM: Carbamazepine induction of apoptosis in cultured cerebellar neurons: effects of N-methyl-D-aspartate, aurintricarboxylic acid and cycloheximide. Brain Res 703: 63-71, 1995
8. Yan GM, Irwin RP, Lin SZ, Weller M, Wood KA, Paul SM: Diphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons. J Pharmacol Exp Ther 274: 983-990, 1995
9. Chen G, Manji HK, Hawver DB, Wright DB, Potter WZ: Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. J Neurochem 63: 2361-2364, 1994
10. Lordo CD, Stroude EC, Del Maestro RF: The effects of diphenylhydantoin on murine astrocytoma radiosensitivity. J Neuro-Oncol 5: 339-350, 1987
11. Ganapathi R, Hercbergs A, Grabowski D, Ford J: Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin). Cancer Res 53: 3262-3265, 1993
12. Tonn JC, Haugland HK, Saraste J, Roosen K, Laerum OD: Differential effects of vincristine and phenytoin on the proliferation, migration, and invasion of human malignant glioma cell lines. J Neurosurg 82: 1035-1043, 1995
13. MacKinney AA, Vyas R, Mueller C, Gorder C: A comparison of potency of hydantoins in metaphase arrest and inhibition of microtubular polymerization. Mol Pharmacol 17: 275-278, 1980
14. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A: Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human malignant glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94: 954-964, 1994
15. Weller M, Malipiero UV, Aguzzi A, Reed JC, Fontana A: Protooncogene bcl-2 gene transfer abrogates Fas/A PO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest 95: 2633-2643, 1995
16. Weller M, Malipiero U, Rensing-Ehl A, Barr P, Fontana A: Fas/APO-1 gene transfer for human malignant glioma. Cancer Res 55: 2936-2944, 1995
17. 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression. Eur J Immunol 24: 1293-1298, 1994
18. Kornblith PL: The role of cytotoxic chemotherapy in the treatment of malignant brain tumors. Surg Neurol 44: 551-552, 1995
19. Weller M, Schmidt C, Roth W, Dichgans J: Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone? Neurology, in press
20. Grossman SA, Sheidler VR, Gilbert MR : D ecreased phenytoin levels in patients receiving chemotherapy. Am J Med 87: 505-510, 1989
21. Slesiger PA, Singer HS: Effects of anticonvulsants on cell growth and enzymatic and receptor binding activity in a neuroblastoma X glioma hybrid cell culture. Epilepsia 28: 214-221, 1987
22. Sironi VA, Ravagnati L, Ettorre G, Cabrini GP, Marossero F: Differences between the concentrations of antiepileptic drugs in normal and pathological human brain. Eur J Clin Pharmacol 22: 447-449, 1982
23. Schnabel R, Rambeck B, May TW, Jürgens U, Lahl R: Concentrations of carbamazepine and carbamazepine-10, 11-epoxide in serum, brain tumors and paratumorous cortex: a prospective study of 37 neurosurgically treated epileptic patients. Eur Neurol 34: 213-220, 1994
24. Pacifici R, Paris L, Di Carlo S, Pichini S, Zuccaro P:Immunologic aspects of carbamazepine treatment in epileptic patients. Epilepsia 32: 122-127, 1991
25. Queiroz ML, Mullen PW: Effects of sodium valproate on the immune response. Int J Immunopharmacol 14: 1133-1137, 1992